In this article we will list the 5 Best German Stocks to Buy According to Analysts. Please visit 10 Best German Stocks to Buy According to Analysts if you’d like see an extended list and how we came up with the list of best value stocks.
5. Allianz SE (OTCMKTS:ALIZY)
Allianz SE (OTCMKTS:ALIZY) is among the best German stocks to buy according to analysts. On February 26, German insurance giant Allianz SE (OTCMKTS:ALIZY) released its Q4 and full-year 2025 report. For the quarter, the operating profit increased 3% YoY to €4.3 billion. For the full-year, the operating profit rose 8.4% to a record of €17.4 billion. Revenue for the year jumped 8.1% to €186.9 billion.
The 2025 results were buoyed by strengths in the property-casualty segment. Operating profit in this segment rose 13.9% to €9.0 billion. Asset Management posted a 3.3% jump in operating profit to €3.3 billion. The health division’s operating profit increased 1.7% to €5.6 billion.
For 2026, Allianz expects operating profit of €17.4 billion, give or take €1 billion. The consensus estimate calls for an operating profit of €18.1 billion.
In other news, Allianz announced a new share repurchase program on February 25. The insurer unveiled a €2.5 billion buyback plan, saying the program would begin in March 2026 and end in December 2026. The company says it will cancel the repurchased shares rather than keep them in its treasury. In addition to the buyback program, Allianz’s management has proposed a dividend per share of €17.10 for 2026.
Allianz SE (OTCMKTS:ALIZY) is a German global financial company better-known for its insurance business. It’s the world’s largest insurer. Beyond insurance, Allianz is engaged in asset management. The company was founded in 1890 and is headquartered in Munich, Germany.
4. Trivago NV (NASDAQ:TRVG)
Trivago NV (NASDAQ:TRVG) is among the best German stocks to buy according to analysts. In its Q4 2025 earnings report, released on February 3, Trivago NV (NASDAQ:TRVG) said its long-term strategy was playing out well, adding that it was confident it can continue to improve growth and profitability.
In Q4, the company’s revenue rose 27% YoY to €120 million. That growth was supported by a 17% jump in Referral revenue, which hit €109.4 million and accounted for the vast majority of the topline. Notably, the Q4 marked the fourth quarter in a row that the Referral business recorded a double-digit YoY revenue growth. The company’s net income for the quarter was €14.5 million. For the full year 2025, total revenue shot up 19% to €548.9. Net income for the year was €11.2 million, and the adjusted EBITDA came to €15.8 million.
Looking ahead to 2026, Trivago NV – ADR said it was off to an encouraging start to the year. For Q1 2026, it expects the double-digital revenue growth to continue. It also expects improved profitability. For full-year 2026, double-digital revenue growth is expected to continue, and adjusted EBITDA is expected to be at least €20 million.
The company sees factors such as continued product improvements and compounding brand effects driving growth in 2026.
Germany-based Trivago NV (NASDAQ:TRVG) operates a global platform for hotel search and price comparison. Trivago says it helps travelers book with confidence. Trivago’s platform provides access to over 7 million hotels in more than 190 countries.
3. SAP SE (NYSE:SAP)
SAP SE (NYSE:SAP) is among the best German stocks to buy according to analysts. On February 24, Bloomberg Law reported that German software company SAP SE (NYSE:SAP) had reached a settlement with Teradata over a long-running dispute. According to the report, the dispute arose in 2018 and hinged on trade secret and antitrust claims against SAP by Teradata. SAP reached a $480 million settlement with Teradata over the matter, averting a court trial that the report said was due to begin shortly.
In other news, SAP announced on February 19 that it planned to distribute €2.92 billion in dividends to shareholders based on its 2025 earnings. The dividend works out to €2.50 per share and represents a payout ratio of 40.7%. Notably, the per share dividend amount represents a 6.4% boost over the dividend the company distributed on its 2024 earnings. Another notable thing is that the payout ratio for 2024 was 52%. SAP plays to pay the dividend on May 8 to shareholders of record as of May 5.
SAP’s dividend boost for 2025 comes after the company reported an 8% jump in total revenue and a 111% rise in IFRS operating profit in the year. The results were supported by substantial growth in cloud revenue. SAP wrapped up the year with €3.4 billion in net liquidity, an increase from €1.7 billion in 2024.
SAP SE (NYSE:SAP) engages in software business, and it’s well-known for its enterprise resource planning software solution. Founded in 1972 and based in Walldorf, Germany, SAP is Germany’s largest enterprise software vendor.
2. Jumia Technologies AG (NYSE:JMIA)
Jumia Technologies AG (NYSE:JMIA) is among the best German stocks to buy according to analysts. On February 11, a day after Jumia Technologies AG (NYSE:JMIA) released its Q4 2025 results, Cantor Fitzgerald cut its price target on Jumia to $16 from $18 while maintaining an Overweight rating on the stock. In that report, the company posted GMV growth that fell short of Cantor’s expectations.
However, Cantor sees Jumia reaching EBITDA break-even by Q4 2026 and achieving full-year profitability in 2027. According to the firm, there’s more room for Jumia to penetrate Africa’s e-commerce market.
On February 10, online marketplace operator Jumia reported its Q4 2025 results. The report showed revenue rose 34% YoY to $61.4 million, though that still fell short of the $62.3 million that analysts were expecting. The topline was supported by a strong growth in GMV, which jumped 36% YoY to $279.5 million.
Adjusted EBITDA loss narrowed to $7.3 million compared to $13.7 million delivered in the fourth quarter of 2024.
The management said the company significantly reduced cash burn during Q4, saying this was supported by improving operating leverage. Jumia finished the quarter with $77.8 million in liquidity.
Looking ahead to 2026, Jumia management said it would focus on refining market footprint, optimizing cost structure, and unlocking operating leverage. Jumia projects GMV growth of between 27% and 32% in both Q1 2026 and full-year 2026.
Founded in 2012, Jumia Technologies AG (NYSE:JMIA) operates an online marketplace and offers logistics and payment services. The company is primarily focused on the African market. It is headquartered in Berlin, Germany.
1. Immatics N.V. (NASDAQ:IMTX)
Immatics N.V. (NASDAQ:IMTX) is among the best German stocks to buy according to analysts. On March 5, Immatics N.V. (NASDAQ:IMTX) reported its financial results for the year ended December 31. It also provided updates on its business.
On the financial part, the company reported revenue of $56.8 million, compared to revenue of $183.1 million in 2024. For the revenue change, the management explained that in 2024, there was a one-time non-cash revenue tied to the company’s deal with Bristol Myers Squibb.
Turning to the bottom line, the company posted a net loss of $230.8 million in 2025, which compared with a net profit of $17.9 million in 2024. The management said the loss was caused by lower non-cash revenue and higher costs associated with advancement of clinical programs.
On business update, Immatics N.V. said Phase 3 SUPRAME trial for its compound called anzu-cel (IMA203) was ongoing, and that the enrollment rate was strong. This trial is on the efficacy, safety, and tolerability of this drug candidate. The anzu-cel therapy is aimed at patients with certain types of melanoma. Immatics expects to begin final analyses of the study data later in 2026. It hopes to seek marketing approval for the drug candidate in the first half of 2027, and then launch the product on the market in the second half of 2027. The company has several other drug candidates in various stages.
Immatics N.V. finished the quarter with $551.4 million in cash and other financial assets.
Immatics N.V. (NASDAQ:IMTX) is a German clinical-stage biopharmaceutical company. It’s focused on developing treatments for cancer patients. Its lead drug candidate, Anzu-cel (IMA203), targets certain types of melanoma.
While we acknowledge the potential of IMTX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IMTX and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 11 Best Affordable Growth Stocks to Buy Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
